


Press Release: InnoSer and its sister company C-Path to offer pathology services in close partnership
Press release | Diepenbeek, 01 April 2021 InnoSer and its sister company C-Path to offer pathology services in close partnership Early 2021, Belgian headquartered preclinical contract research organization (CRO) InnoSer gathered its brands under the umbrella of...
BlastomaBrain: New in vitro platform for oncology drug development
One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...
Press Release: InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications
Press release | Leiden, 25 January 2021 InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications Commercial availability of the in vitro glioblastoma Minibrain organoid platform paves the way for personalized medicine...
InnoSer offers new in vivo imaging capabilities
InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
Recent Comments